CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug t...
Leadership
John J. Alam M.D.Founder
Co-Founder, CEO, President & Director
Sylvie L. Gregoire Pharm.D.Founder
Co-Founder & Director
William Robert Elder J.D.
CFO, General Counsel & Corporate Secretary
Kelly Blackburn M.H.A.
Executive Vice President of Clinical Development
Marinus Verwijs Ph.D.
Executive Vice President of Technical Operations
Mark A. De Rosch Ph.D.
Executive VP of Regulatory, Government Affairs & Program Management
